Introduction to the main ingredients of amygdalin

Amygdalin is a cyanogenic glycoside compound with a chemical structure containing a cyano group. When amygdalin encounters the action of specific enzymes in the body, it releases hydrocyanic acid (HCN), a component that is toxic to cells. Therefore, amygdalin has attracted attention in the medical community, but its safety and effectiveness are still under further research.

 

Potential benefits of amygdalin in cancer care

1. Anti-cancer potential: Amygdalin releases hydrogen cyanide in the body Acid may theoretically be toxic to cancer cells and hinder their proliferation. However, this mechanism also affects healthy cells, so careful dosage control is required.
2. Immune Support: Research shows that low doses of amygdalin may Helps activate immune cells, such as NK cells, thereby enhancing the body’s anti-cancer response.
3. Cancer Pain Management: Some small studies show that amygdalin May help relieve pain in cancer patients. This may be related to the slight anesthetic effect of its metabolites, but the specific mechanism has yet to be verified.

The mechanism of action of amygdalin in cancer care

The mechanism of action of amygdalin is mainly due to the toxic effect of its metabolite hydrocyanic acid. Cancer cells contain higher levels of β-glucosidase, which can break down amygdalin and release cyanide, which has a toxic effect on cancer cells. However, since cyanide is also toxic to normal cells, how to effectively exploit this mechanism is still under investigation.

 

Clinical study of amygdalin in cancer care

1. Anti-cancer toxicity study: In in vitro experiments, amygdalin Shows toxicity against certain cancer cells, but with mixed results in animal and human trials. For example, a study in “Cancer Treatment Reports” showed that amygdalin can cause serious toxic reactions when the dose is too high and should be used with caution.
2. Cancer pain management: Some clinical trials show that cancer patients are using After amygdalin, the pain was reduced. This may be related to the mild anesthetic effect of its metabolites, but the specific mechanism still needs further study.
3. Immune system support: Low-dose amygdalin has beneficial effects on the immune system Potential supportive roles are also explored. Studies have shown that amygdalin can enhance the activity of immune cells to a certain extent and help enhance the immune function of cancer patients.

Conclusion

Amygdalin has shown some potential benefits as a possible anti-cancer supplement. However, current research has not fully verified its safety and effectiveness due to the risk of toxicity posed by its hydrocyanic acid-releasing properties. Therefore, the application of amygdalin in cancer care still needs further clinical trial verification, and it is recommended to use it with caution under the guidance of a doctor.

 

Academic References

1. Moertel,C.G., et al. (1982). vitaminsB17Clinical Trial in Cancer. New England Journal of Medicine, 306(4), 201- 206.
2. Sweet,F., et al. (1974). Amygdalin Cytotoxicity and its application in cancer treatment. Cancer Treatment Reports, 58(5), 729-738.
3. Milazzo,S., et al. (2006). Amygdalin in Systematic reviews and safety analyzes in cancer treatment. Cochrane Database of Systematic Reviews, CD005476.

Medical Disclaimer:

The information provided in this article is for educational and reference purposes only and does not constitute medical advice and should not be relied upon Used as a substitute for professional medical diagnosis, treatment or advice. Always consult your physician or other qualified health professional with any questions you may have regarding your medical condition or medical problems. The content of this article is not intended to recommend any specific test, treatment, or medication and should not be considered such advice. If you develop symptoms or need medical assistance, please contact a medical professional promptly.